                            SEQUENCE LISTING

<110> Axel Emanuel Stenmark Tullberg
      Erik Carl Viktor Holmberg
      Per Oswald Karlsson
      Troy M. Bremer

<120> PD-1 AS A PREDICTIVE MARKER FOR THERAPY
  IN CANCER

<130> PRLUD.010WO

<150> US 63/169532        
<151> 2021-04-01  

<150> SE 2050559-0        
<151> 2020-05-13  

<160> 4

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 2097
<212> DNA
<213> Unknown
<220>
<223> cDNA

<400> 1
gctcacctcc gcctgagcag tggagaaggc ggcactctgg tggggctgct ccaggcatgc 60
agatcccaca ggcgccctgg ccagtcgtct gggcggtgct acaactgggc tggcggccag 120
gatggttctt agactcccca gacaggccct ggaacccccc caccttctcc ccagccctgc 180
tcgtggtgac cgaaggggac aacgccacct tcacctgcag cttctccaac acatcggaga 240
gcttcgtgct aaactggtac cgcatgagcc ccagcaacca gacggacaag ctggccgcct 300
tccccgagga ccgcagccag cccggccagg actgccgctt ccgtgtcaca caactgccca 360
acgggcgtga cttccacatg agcgtggtca gggcccggcg caatgacagc ggcacctacc 420
tctgtggggc catctccctg gcccccaagg cgcagatcaa agagagcctg cgggcagagc 480
tcagggtgac agagagaagg gcagaagtgc ccacagccca ccccagcccc tcacccaggc 540
cagccggcca gttccaaacc ctggtggttg gtgtcgtggg cggcctgctg ggcagcctgg 600
tgctgctagt ctgggtcctg gccgtcatct gctcccgggc cgcacgaggg acaataggag 660
ccaggcgcac cggccagccc ctgaaggagg acccctcagc cgtgcctgtg ttctctgtgg 720
actatgggga gctggatttc cagtggcgag agaagacccc ggagcccccc gtgccctgtg 780
tccctgagca gacggagtat gccaccattg tctttcctag cggaatgggc acctcatccc 840
ccgcccgcag gggctcagct gacggccctc ggagtgccca gccactgagg cctgaggatg 900
gacactgctc ttggcccctc tgaccggctt ccttggccac cagtgttctg cagaccctcc 960
accatgagcc cgggtcagcg catttcctca ggagaagcag gcagggtgca ggccattgca 1020
ggccgtccag gggctgagct gcctgggggc gaccggggct ccagcctgca cctgcaccag 1080
gcacagcccc accacaggac tcatgtctca atgcccacag tgagcccagg cagcaggtgt 1140
caccgtcccc tacagggagg gccagatgca gtcactgctt caggtcctgc cagcacagag 1200
ctgcctgcgt ccagctccct gaatctctgc tgctgctgct gctgctgctg ctgctgcctg 1260
cggcccgggg ctgaaggcgc cgtggccctg cctgacgccc cggagcctcc tgcctgaact 1320
tgggggctgg ttggagatgg ccttggagca gccaaggtgc ccctggcagt ggcatcccga 1380
aacgccctgg acgcagggcc caagactggg cacaggagtg ggaggtacat ggggctgggg 1440
actccccagg agttatctgc tccctgcagg cctagagaag tttcagggaa ggtcagaaga 1500
gctcctggct gtggtgggca gggcaggaaa cccctccacc tttacacatg cccaggcagc 1560
acctcaggcc ctttgtgggg cagggaagct gaggcagtaa gcgggcaggc agagctggag 1620
gcctttcagg cccagccagc actctggcct cctgccgccg cattccaccc cagcccctca 1680
caccactcgg gagagggaca tcctacggtc ccaaggtcag gagggcaggg ctggggttga 1740
ctcaggcccc tcccagctgt ggccacctgg gtgttgggag ggcagaagtg caggcaccta 1800
gggcccccca tgtgcccacc ctgggagctc tccttggaac ccattcctga aattatttaa 1860
aggggttggc cgggctccca ccagggcctg ggtgggaagg tacaggcgtt cccccggggc 1920
ctagtacccc cgccgtggcc tatccactcc tcacatccac acactgcacc cccactcctg 1980
gggcagggcc accagcatcc aggcggccag caggcacctg agtggctggg acaagggatc 2040
ccccttccct gtggttctat tatattataa ttataattaa atatgagagc atgctaa    2097

<210> 2
<211> 20
<212> DNA
<213> Unknown
<220>
<223> Synthetic Primer

<400> 2
cgtggcctat ccactcctca                                             20

<210> 3
<211> 20
<212> DNA
<213> Unknown
<220>
<223> Synthetic Primer

<400> 3
atcccttgtc ccagccactc                                             20

<210> 4
<211> 287
<212> PRT
<213> Unknown
<220>
<223> Mammal

<400> 4
Met Gln Ile Pro Gln Ala Pro Trp Pro Val Val Trp Ala Val Leu Gln
 1               5                  10                  15      
Leu Gly Trp Arg Pro Gly Trp Phe Leu Asp Ser Pro Asp Arg Pro Trp
            20                  25                  30          
Asn Pro Pro Thr Phe Ser Pro Ala Leu Leu Val Val Thr Glu Gly Asp
        35                  40                  45              
Asn Ala Thr Phe Thr Cys Ser Phe Ser Asn Thr Ser Glu Ser Phe Val
    50                  55                  60                  
Leu Asn Trp Tyr Arg Met Ser Pro Ser Asn Gln Thr Asp Lys Leu Ala
65                  70                  75                  80  
Ala Phe Pro Glu Asp Arg Ser Gln Pro Gly Gln Asp Cys Arg Phe Arg
                85                  90                  95      
Val Thr Gln Leu Pro Asn Gly Arg Asp Phe His Met Ser Val Val Arg
            100                 105                 110         
Ala Arg Arg Asn Asp Ser Gly Thr Tyr Leu Cys Gly Ala Ile Ser Leu
        115                 120                 125             
Ala Pro Lys Ala Gln Ile Lys Glu Ser Leu Arg Ala Glu Leu Arg Val
    130                 135                 140                 
Thr Glu Arg Arg Ala Glu Val Pro Thr Ala His Pro Ser Pro Ser Pro
145                 150                 155                 160 
Arg Pro Ala Gly Gln Phe Gln Thr Leu Val Val Gly Val Val Gly Gly
                165                 170                 175     
Leu Leu Gly Ser Leu Val Leu Leu Val Trp Val Leu Ala Val Ile Cys
            180                 185                 190         
Ser Arg Ala Ala Arg Gly Thr Ile Gly Ala Arg Arg Thr Gly Gln Pro
        195                 200                 205             
Leu Glu Asp Pro Ser Ala Val Pro Val Phe Ser Val Asp Tyr Gly Glu
    210                 215                 220                 
Leu Asp Phe Gln Trp Arg Glu Lys Thr Pro Glu Pro Pro Val Pro Cys
225                 230                 235                 240 
Val Pro Glu Gln Thr Glu Tyr Ala Thr Ile Val Phe Pro Ser Gly Met
                245                 250                 255     
Gly Thr Ser Ser Pro Ala Arg Arg Gly Ser Ala Asp Gly Pro Arg Ser
            260                 265                 270         
Ala Gln Pro Leu Arg Pro Glu Asp Gly His Cys Ser Trp Pro Leu
        275                 280                 285         


